Be notified when new investment ideas go online. Just enter your email address:
Great Ideas
Penwest Pharmaceuticals...Growing royalty income from extended release pain drug to move Penwest into black in 2010.
Amedisys...Shares sharply undervalued on strong growth prospects. Acquisitions likely to boost near term results.
ACADIA Pharmaceuticals... Disappointing clinical trial results for Parkinson's disease psychosis drug creates opportunity for aggressive investors.
No news available yet.
Orexigen (NADSAQ: OREX) likely to continue upward trend on strength of positive results from obesity drug trials. Prospects are highly positive.
BSD Medical (NASDAQ: BSDM) shares modestly priced and will surge should company's heat therapy system win FDA approval.
Methode Electronics (NYSE: MEI) should move to low teens on growing strength of European business.
Opexa Therapeutics (NASDAQ: OPXA) Still room to climb. Success with multiple sclerosis drug could put market cap at hundreds of millions of dollars. Huge potential. Huge risk.
Novavax, Inc. (NASDAQ: NVAX) Flu vaccine developer still has to prove itself in Phase III trials. Shares continue vulnerable.
